secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001493152-24-044154
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.02, 2.03, 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical Q3 revenue down 4% to $11.5M; cuts FY24 guidance; workforce –25%
-----------------------------------------------------------------------------

- Net loss $4.7M ($0.14/share) vs $4.6M YoY; adjusted EBITDA loss $2.4M.
- Total revenue $11.5M (Advanced Energy -6% to $9.3M; OEM +3% to $2.2M).
- FY24 revenue guidance cut to $46.6-47.6M from prior $50.6-52.1M; net loss expected ~$25M.
- Raised ~$7M via registered direct offering of 3M shares + pre-funded warrants at $1.18/share.
- Reduced U.S. workforce ~25% for ~$4.3M annual savings; three directors resigned; COO appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-044154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer